Opportunity Enterprises
Analysis
Opportunity Enterprises is a registered charity in United States, based in Auburn, ME. It received its IRS tax-exemption ruling in March 2009, 17 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending June 2024, Opportunity Enterprises reported income of $7.4m and spending of $7.9m, spending 106% of what it took in. Across the 5 years on record, from June 2020 to June 2024, income fell from $7.8m to $7.4m (-5.4%), an average of -1.4% a year. Over the whole period it spent 95% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Opportunity Enterprises sits at the 82nd percentile: it is larger than about 82% of them. Against every charity in United States with reported income it ranks in the 94th percentile, and in the 93rd percentile within ME. Charities of a similar size with the same main cause include Vitalyst Health Foundation ($7.4m), Eb Research Partnership Inc ($7.4m) and Methodist Transplant Physicians ($7.4m).
On its Form 990 for the period ending June 2024, revenue came from contributions and grants 0.6% and program service revenue 99% of the total. Compensation of current officers, directors and key employees was $89k (1.1% of expenses). Other salaries and wages came to $4.6m. At year end it held assets of $5.3m against liabilities of $955k, net assets of $4.3m. It reported 185 employees.
Income and spending
Where the income comes from
- Contributions & grants 0.6%
- Program services 99%
- Other 0.2%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Vitalyst Health Foundation | Phoenix | $7.4m |
| Eb Research Partnership Inc | New York | $7.4m |
| Methodist Transplant Physicians | Dallas | $7.4m |
| CCSG Inc | Thomasville | $7.4m |